Table 1.

Description of the cited strains.

Strains	Description	Ref.
B. subtilis
ΔΔ	genes that encode the multidrug transporters Bmr and Blt are genetically inactivated	[26]
ΔΔNA	expresses a functional NorA transporter from the plasmid expression vector pBEV	[27]
S. aureus
SA-1199	wild-type	[27]
SA-1199B	overexpresses the chromosomal norA gene which harbors a mutation in grlA	[28]
8325-4	wild-type	[29]
K1758	ΔnorA	[30]
K2361	SA-K1758 with pK364:norA	[31]
ATCC 25923	wild-type
SA-K2378	having a plasmid that results in overexpression of norA from S. aureus SA1199	[32]
SA-K1902	ΔnorA	[32]
E. aerogenes
ATCC 13048	wild-type
ATCC 13048 p9	overexpressing the EP activator marA gene	[33]
EA27	overexpressing EP, clinically isolated	[34]
EA3	overexpressing EP, clinically isolated	[34]
EA5	overexpressing EP, clinically isolated	[34]
CM-64	resistant to CAF due to EP overexpressing,	[35]
EA117	low porin levels and also substitutions in the QRDR domain of GrlA	[36]
EA289	overexpressing AcrAB–TolC pump	[36]
E. coli
AG100	wild-type
AG100A	AcrAB pump-deficient	[37]
AG100tet	overexpressing efflux pump	[38]
ATCC 25922	wild-type
YD02	multidrug-resistant after induction from ATCC 25922	[39]
P. aeruginosa
ATCC 27853	wild-type
K. pneumoniae
KP55	porin deficient phenotype	[40]
M. smegmatis mc2155
ATCC 700084	wild-type	[41]
M. avium
104	wild-type	[42]
104CLA3	resistant to CLA due to overexpression of efflux pumps	[43]
104CLA4	resistant to CLA due to overexpressing efflux pumps and harboring the mutation A-2059G in 23S rRNA	[43]